MAR 13, 2015 02:04 PM PDT

Alzheimer's Breakthrough Uses Ultrasound Technology

Queensland scientists have found that non-invasive ultrasound technology can be used to treat Alzheimer's disease and restore memory.

University of Queensland researchers discovered that the innovative drug-free approach breaks apart the neurotoxic amyloid plaques that result in memory loss and cognitive decline.

Welcoming the findings today at UQ's Queensland Brain Institute, Queensland Premier Annastacia Palaszczuk said they could have a wide impact for the community.

"The Government's $9 million investment into this technology was to drive discoveries into clinics, and today's announcement indicates that together with the Queensland Brain Institute, it was a worthwhile investment," Ms Palaszczuk said.

"I want my Government to encourage more of this type of innovative research.

"Our Advance Queensland initiative aims to increase research and discoveries like this and to put this state's research at the forefront internationally by supporting local researchers and helping to keep them in Queensland.

"These exciting findings will hopefully be of benefit to all Australians in the future."

QBI Founding Director Professor Perry Bartlett said the discovery - a result of ‘game-changing' work performed at the Queensland Brain Institute's Clem Jones Centre for Ageing Dementia Research - was made possible through the support of the State and Federal Governments and philanthropic support led by the Clem Jones Foundation.

"The farsighted investment of government and philanthropic partners has allowed us to build the research excellence and capacity required to make major discoveries such as this," Professor Perry Bartlett said.

"I believe the work opens up an entirely novel avenue for future therapeutic treatment."

Clem Jones Centre for Ageing Dementia Research director Professor Jürgen Götz said the new treatment method could revolutionise Alzheimer's treatment by restoring memory.

"We're extremely excited by this innovation of treating Alzheimer's without using drug therapeutics," Professor Götz said.

"The ultrasound waves oscillate tremendously quickly, activating microglial cells that digest and remove the amyloid plaques that destroy brain synapses.

"The word ‘breakthrough' is often mis-used, but in this case I think this really does fundamentally change our understanding of how to treat this disease, and I foresee a great future for this approach."

Alzheimer's affects more than two-thirds of dementia patients, and approximately a quarter of a million Australians.

The total number of dementia cases in Australia is expected to rise to 900,000 by 2050.

"With an ageing population placing an increasing burden on the health system, an important factor is cost, and other potential drug treatments using antibodies will be expensive," Professor Götz said.

"In contrast, this method uses relatively inexpensive ultrasound and microbubble technology which is non-invasive and appears highly effective.

The approach is able to temporarily open the blood-brain barrier, activating mechanisms that clear toxic protein clumps and restoring memory functions.

"With our approach the blood-brain barrier's opening is only temporary for a few hours, so it quickly restores its protective role," Professor Götz said.

Research has been conducted using mice with an Alzheimer's model, with the next step being to scale the research in higher animal models ahead of human clinical trials, which are at least two years away.

"This treatment restored memory function to the same level of normal healthy mice," Professor Götz said.

"We're also working on seeing whether this method clears toxic protein aggregates in neurodegenerative diseases other than Alzheimer's and whether this also restores executive functions, including decision-making and motor control."

Source: University of Queensland
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 17, 2018
Cell & Molecular Biology
SEP 17, 2018
A Fast New Method to Make an Important Type of Brain Cell
Scientists have developed a better way to create astrocytes, a cell type hat has been implicated in neurodegenerative diseases....
OCT 10, 2018
Videos
OCT 10, 2018
Are Personality Tests Scientifically Accurate?
Personality tests like the Minnesota Multiphasic Personality Inventory and others are used to find out what a person is like, internally. They measure reac...
OCT 16, 2018
Genetics & Genomics
OCT 16, 2018
Lab-grown Neurons Help Uncover the Genetic Changes Underlying Mental Illness
Developing therapeutics that will effectively relieve mental illness means understanding what is causing those disorders in the first place....
OCT 29, 2018
Neuroscience
OCT 29, 2018
Gut: a second brain and novel therapeutic target
Undersatnding the role of gut microbiome in disease pathologies and targetting them for potential treatment strategies....
NOV 06, 2018
Cannabis Sciences
NOV 06, 2018
The Role of Endocannabinoids in Orgasm
Now that I've got your attention, we can talk science now. Yes, there is actually relatively new study which measures levels of endocannabinoids in blo...
NOV 13, 2018
Drug Discovery
NOV 13, 2018
Clinical Trial Drug For a Rare Neurodegenrative Disease Proven Unsuccessful
Niemann-Pick type C (NPC) is a rare and fatal neurodegenerative disease. Symptoms of the condition include loss of balance, difficulty swallowing, seizures...
Loading Comments...